文献速递糖尿病肥胖与代谢综合征

微小RNA-193b通过靶向PDK1/Akt信号通路损害2型糖尿病小鼠模型的肌肉生长

MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway.
PubMed 文献 · Diabetologia · 2021-12-16

研究探讨miR-193b在2型糖尿病相关骨骼肌萎缩中的作用。在C57BLKS/J小鼠中过表达miR-193b、在db/db小鼠中抑制miR-193b,并在C57BL/6J小鼠中胫骨前肌特异性敲除PDK1。结果发现2型糖尿病患者血清miR-193b升高且与肌肉量负相关,miR-193b通过靶向Pdk1抑制Akt/mTOR/S6K通路减少蛋白合成。

要点

  • 2型糖尿病患者血清miR-193b水平升高,且与肌肉量呈负相关。
  • AAV介导miR-193b过表达诱导健康小鼠肌肉丢失和功能障碍。
  • 抑制miR-193b减轻db/db小鼠肌肉丢失和功能障碍。

核心结论

  • 研究结果揭示了miR-193b在肌肉功能和质量中先前未被认识的作用,可能成为治疗肌肉减少症的潜在治疗靶点。

研究设计与样本

  • 在C57BLKS/J小鼠中采用AAV介导骨骼肌miR-193b过表达,在db/db小鼠中采用骨骼肌miR-193b缺失,以探究miR-193b在肌肉丢失中的功能。
  • 在C57BL/6J小鼠中通过原位AAV注射介导胫骨前肌特异性敲除PDK1,以确认miR-193b是否通过PDK1调控肌肉生长。
  • 分析健康个体(n=20)和2型糖尿病患者(n=20)的血清miR-193b水平,并评估其与HbA1c、空腹血糖、体成分、甘油三酯和C肽的相关性。

主要发现

  • 2型糖尿病患者血清miR-193b水平升高,且在这些参与者中与肌肉量呈负相关。
  • AAV介导的miR-193b过表达诱导健康小鼠肌肉丢失和功能障碍。
  • 抑制miR-193b减轻db/db小鼠的肌肉丢失和功能障碍。
  • miR-193b靶向Pdk1表达以失活Akt/mTOR/S6K通路,从而抑制蛋白合成。
  • 在健康小鼠中敲低PDK1阻断了miR-193b诱导的Akt/mTOR/S6K通路失活和肌肉生长受损。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Type 2 diabetes is associated with a reduction in skeletal muscle mass; however, how the progression of sarcopenia is induced and regulated remains largely unknown. We aimed to find out whether a specific microRNA (miR) may contribute to skeletal muscle atrophy in type 2 diabetes. METHODS: Adeno-associated virus (AAV)-mediated skeletal muscle miR-193b overexpression in C57BLKS/J mice, and skeletal muscle miR-193b deficiency in db/db mice were used to explore the function of miR-193b in muscle loss. In C57BL/6 J mice, tibialis anterior-specific deletion of 3-phosphoinositide-dependent protein kinase-1 (PDK1), mediated by in situ AAV injection, was used to confirm whether miR-193b regulates muscle growth through PDK1. Serum miR-193b levels were also analysed in healthy individuals (n = 20) and those with type 2 diabetes (n = 20), and correlations of miR-193b levels with HbA1c, fasting blood glucose (FBG), body composition, triacylglycerols and C-peptide were assessed. RESULTS: In this study, we found that serum miR-193b levels increased in individuals with type 2 diabetes and negatively correlated with muscle mass in these participants. Functional studies further showed that AAV-mediated overexpression of miR-193b induced muscle loss and dysfunction in healthy mice. In contrast, suppression of miR-193b attenuated muscle loss and dysfunction in db/db mice. Mechanistic analysis revealed that miR-193b could target Pdk1 expression to inactivate the Akt/mammalian target of rapamycin (mTOR)/p70S6 kinase (S6K) pathway, thereby inhibiting protein synthesis. Therefore, knockdown of PDK1 in healthy mice blocked miR-193b-induced inactivation of the Akt/mTOR/S6K pathway and impairment of muscle growth. CONCLUSIONS/INTERPRETATION: Our results identified a previously unrecognised role of miR-193b in muscle function and mass that could be a potential therapeutic target for treating sarcopenia.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Yang S, Yang G, Wu H, et al. MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway. Diabetologia. 2021. PMID: 34913989. doi:10.1007/s00125-021-05616-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。